MOS-101

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameMOS-101
Drug Alias NameASTX-295 + olaparibMOS-101
ClassificationSmall molecules
Mechanisms of Actionp53-binding protein Mdm-2 inhibitorsPoly (ADP-Ribose) polymerase inhibitors
Targetsp53-binding protein Mdm-2Poly (ADP-Ribose) polymerase
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMosaic Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMosaic Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A